CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer.
September 10th 2021
An ovarian cancer survivor shares what it was like to be her late husband’s caregiver when he had prostate cancer, years before her own diagnosis.
August 18th 2021
Widowers were more likely to be diagnosed with prostate cancer that had distant metastases, according to recent research.
August 13th 2021
From the state of the “Tiger King’s” Joe Exotic’s prostate cancer to the emotional reunion of two 3-year-old cancer survivors, here’s what’s happening in the cancer landscape this week.
August 2nd 2021
Our first imperative as cancer survivors is to travel on a journey of wellness and peace of mind, not fear and stress.
July 30th 2021
Articles containing misinformation on social media sites like Facebook and Twitter were more likely to be shared and liked than those with accurate information.
July 26th 2021
A survivor of prostate cancer celebrates the news that his cancer has not spread and describes how remission has made him feel.
July 20th 2021
Despite this “obesity paradox,” doctors do not recommend gaining weight with hopes of improving cancer outcomes.
June 21st 2021
The disease, which advanced to his spine and bones, prevented him from appearing onstage for the “Friends” reunion.
June 16th 2021
Reaching a younger age group of African American men for prostate cancer detection may improve their survival outcomes, says an expert from the University of California San Diego.
June 7th 2021
The treatment was also associated with antitumor activity in patients with metastatic castration-resistant prostate cancer.
June 6th 2021
Patients with nonmetastatic castration-resistant prostate cancer continued to tolerate long-term treatment with Nubeqa, allowing them to maintain their quality of life and remain on therapy.
June 5th 2021
The data, according to one of the study’s authors, are critical in understanding the disparities in prostate cancer.
June 4th 2021
The addition of an investigational therapy to standard-of-care treatment was associated with a median overall survival of 15.3 months in patients with progressive PSMA-positive metastatic castration-resistant prostate cancer.
May 27th 2021
The PET imaging agent targets prostate-specific membrane antigen levels, which can improve the detection of suspected disease spread or recurrence compared with standard approaches.
May 21st 2021
The study results lend strength to discuss prostate cancer screening in younger Black men, according to an expert.
May 21st 2021
From Al Roker’s cancer screening advice to the death of actor Charles Grodin, here’s what’s happening in the cancer landscape this week.
May 6th 2021
In this episode of the “CURE® Talks Cancer” podcast, Leanne Burnham, Ph.D., discusses the research she’s working on to address health disparities in Black men with prostate cancer after being inspired by her father’s diagnosis, and shares her own cancer survival story.
April 28th 2021
A recent analysis of veterans with prostate cancer showed that they are not being assessed and treated for cardiovascular risk factors at the rate they should be to optimize survival, particularly when being treated with androgen deprivation therapy, which has been associated with increased risk for cardiovascular disease.
March 28th 2021
A prostate cancer survivor recalls a time when the cancer center’s staff helped him realize that its OK to have fun while receiving cancer treatment.
March 14th 2021
Never say to someone that at least they have a “good” kind of cancer or that they don’t really look that sick, writes one cancer survivor.
March 11th 2021
The Food and Drug Administration’s recent approval of the first oral hormone therapy, Orgovyx, for the treatment of advanced prostate cancer has positioned the drug to become a standard of care for patients, according to an expert.
March 7th 2021
A survivor takes a closer look at the trouble with using the phrase “cancer-free” when discussing the disease with friends and family.
February 25th 2021
Here is a list of some recent trials that launched within the cancer space in February.
February 21st 2021
“Did you hear the one about the cancer procedure that went terribly wrong?” “It turned out to be a ‘bi-oopsie!’”
February 12th 2021
The combination of Erleada, Zytiga and the steroid prednisone was associated with a trend toward better survival outcomes in certain patients with chemotherapy-naive metastatic castration-resistant prostate cancer.
February 12th 2021
Instead of buying your sweetheart chocolates for Valentine’s Day this year, one cancer survivor suggests people get screened as a gift to their significant other.
February 3rd 2021
Patients with prostate cancer experienced no significant difference in quality of life when treated with two different types of radiation regimens, recent research has found.
January 26th 2021
At three years, overall survival in men with nonmetastatic, castration-resistant prostate cancer treated with Nubeqa was 83% compared with 77% in those who received placebo.
January 13th 2021
Men who are receiving androgen deprivation therapy treatment for prostate cancer experience higher levels of fatigue and depression when compared to men who are not receiving treatment and who have no history of cancer.